MAGEA4 and synovial sarcoma: demonstrated in synovial sarcomas that CTAs were often coexpressed (51% of SS expressed NY-ESO-1 and MAGE-A4 and PRAME) and their expression was associated with a higher grade and a trend to poorer OS (74).